HemaSphere (Jun 2022)

P493: SINGLE CENTER EXPERIENCE OF VENETOCLAX (VEN) IN COMBINATION WITH FLAG-IDA IN PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

  • Y. Abaza,
  • T. Khan,
  • S. Dinner,
  • O. Frankfurt,
  • J. K. Altman

DOI
https://doi.org/10.1097/01.HS9.0000844860.26267.ba
Journal volume & issue
Vol. 6
pp. 392 – 393

Abstract

Read online

No abstracts available.